Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

CHART Thread, page-980

First 980 Last

Share
Profile

Follow
Driver1

499 Posts.

73

24/08/21

20:05

Post #: 55539761
Share

Originally posted by Chaya: ↑

Hi jo - thought you gals and guys might be interested in a chat I had on my car phone with the "Man" on the way to get my Pfizer jab earlier today.

Joel is OK with me passing part of that conversation onto the IHL faithful on HC.

News wise it will be quiet from now to the listing news but daily he is accepting calls from the USA from many, very deep pocketed investors associated with our already selected/accepted USA investment bank.
The interest from that country is through the "proverbial roof" and I doubt I will do it justice to pass on Joel's excitement and enthusiasm with what we have looming in front of us. He tells me that it is very difficult to try to even suppress the expectations from these wealthy investors.

The SEC I'm told can at times ask for up to 100 to 500 points to be clarified or questions answered and if that happens, Joel will assemble a team dedicated to answering those questions as quickly as humanly possible but knowing Joel and his team and going on past performances, I doubt we will strike many issues at all but there will be some no doubt.

IMO, the next few weeks will be the last chance we all get to feather our nests further before its rather expensive to expand the IHL portfolio any further.

There are some very smart posters on these threads and its rare to read such a common agreed opinion about the future of a company and the fact that there is basically zero detractors present spells it out very clearly to me - we are all expecting a brilliant future for IHL.

Expand

Wow, great news, kudos to Joel and yourself.
Got a saw head from hitting the cab roof, don't know if it's the crap national Hwys or just me bouncing up and down on the suspension seat with glee

IHL Price at posting: 37.0¢ Sentiment: Hold Disclosure: Held
21 Upvote

0 Great analysis

Reply

Top Stories

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA